![Surviving-an-FDA-GCP-Inspection-500.jpg Surviving an FDA GCP Inspection](https://www.centerwatch.com/ext/resources/products/Surviving-an-FDA-GCP-Inspection-500.jpg?height=200&t=1605810958&width=200)
Home » Yabao Pharmaceuticals, MRC Technology partner in China
Yabao Pharmaceuticals, MRC Technology partner in China
November 26, 2014
China-based Yabao Pharmaceutical has inked an exclusive license with MRC Technology, a U.K. medical research charity, to discover, develop and commercialize innovative products targeting a kinase target for neurodegeneration for the treatment of Parkinson's disease.
Yabao receives exclusive rights to discover, develop and commercialize in China and Taiwan, while MRC Technology retains rights in all other markets. Financial terms have not been disclosed.
Upcoming Events
-
21Oct